NOVONIX Ltd Files Form 6-K
Ticker: NVNXF · Form: 6-K · Filed: Nov 27, 2024 · CIK: 1859795
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
NOVONIX filed a 6-K on Nov 27, showing Exhibit 99.1 is a 'Request for T'.
AI Summary
NOVONIX Ltd filed a Form 6-K on November 27, 2024, reporting information as of November 26, 2024. The filing includes an Exhibit Index, with Exhibit 99.1 being a 'Request for T'. The company is incorporated in Australia and its fiscal year ends on December 31.
Why It Matters
This filing provides an update on the company's reporting status and includes an index of exhibits, which may contain further details relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing that primarily serves as an index and does not appear to contain significant new financial or operational information.
Key Players & Entities
- NOVONIX Ltd (company) — Registrant
- November 27, 2024 (date) — Filing Date
- November 26, 2024 (date) — Period of Report Date
- Exhibit 99.1 (document) — Included Exhibit
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is November 27, 2024.
What is the period of report for this filing?
The conformed period of report for this filing is November 26, 2024.
What exhibits are listed in this filing?
The filing lists an Exhibit Index, with Exhibit 99.1 described as 'Request for T'.
Where is NOVONIX Ltd's principal executive office located?
NOVONIX Ltd's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Filing Stats: 251 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2024-11-27 16:26:12
Filing Documents
- nvx-6k-nov-24-11-26_equi.htm (6-K) — 30KB
- nvx-ex99_1.htm (EX-99.1) — 13KB
- nvx-ex99_2.htm (EX-99.2) — 78KB
- nvx-ex99_3.htm (EX-99.3) — 189KB
- nvx-ex99_4.htm (EX-99.4) — 179KB
- nvx-ex99_5.htm (EX-99.5) — 42KB
- nvx-ex99_6.htm (EX-99.6) — 16KB
- img58969013_0.jpg (GRAPHIC) — 15KB
- img58969013_1.jpg (GRAPHIC) — 3KB
- img59892534_0.jpg (GRAPHIC) — 56KB
- img60816055_0.jpg (GRAPHIC) — 663KB
- img60816055_1.jpg (GRAPHIC) — 841KB
- img60816055_2.jpg (GRAPHIC) — 974KB
- img60816055_3.jpg (GRAPHIC) — 973KB
- img60816055_4.jpg (GRAPHIC) — 657KB
- img60816055_5.jpg (GRAPHIC) — 693KB
- img60816055_6.jpg (GRAPHIC) — 282KB
- img60816055_7.jpg (GRAPHIC) — 587KB
- img60816055_8.jpg (GRAPHIC) — 382KB
- img60816055_9.jpg (GRAPHIC) — 425KB
- img60816055_10.jpg (GRAPHIC) — 264KB
- img60816055_11.jpg (GRAPHIC) — 473KB
- img60816055_12.jpg (GRAPHIC) — 510KB
- img60816055_13.jpg (GRAPHIC) — 443KB
- img60816055_14.jpg (GRAPHIC) — 514KB
- img60816055_15.jpg (GRAPHIC) — 514KB
- img60816055_16.jpg (GRAPHIC) — 456KB
- img60816055_17.jpg (GRAPHIC) — 450KB
- img60816055_18.jpg (GRAPHIC) — 517KB
- img60816055_19.jpg (GRAPHIC) — 581KB
- img60816055_20.jpg (GRAPHIC) — 630KB
- img60816055_21.jpg (GRAPHIC) — 424KB
- img60816055_22.jpg (GRAPHIC) — 523KB
- img60816055_23.jpg (GRAPHIC) — 492KB
- img60816055_24.jpg (GRAPHIC) — 535KB
- img60816055_25.jpg (GRAPHIC) — 253KB
- img60816055_26.jpg (GRAPHIC) — 455KB
- img60816055_27.jpg (GRAPHIC) — 526KB
- img60816055_28.jpg (GRAPHIC) — 429KB
- img60816055_29.jpg (GRAPHIC) — 492KB
- img60816055_30.jpg (GRAPHIC) — 463KB
- img60816055_31.jpg (GRAPHIC) — 351KB
- img60816055_32.jpg (GRAPHIC) — 393KB
- img60816055_33.jpg (GRAPHIC) — 610KB
- img60816055_34.jpg (GRAPHIC) — 862KB
- img60816055_35.jpg (GRAPHIC) — 785KB
- img60816055_36.jpg (GRAPHIC) — 728KB
- img60816055_37.jpg (GRAPHIC) — 750KB
- img60816055_38.jpg (GRAPHIC) — 671KB
- img60816055_39.jpg (GRAPHIC) — 759KB
- img60816055_40.jpg (GRAPHIC) — 889KB
- img60816055_41.jpg (GRAPHIC) — 594KB
- img60816055_42.jpg (GRAPHIC) — 754KB
- img60816055_43.jpg (GRAPHIC) — 674KB
- img60816055_44.jpg (GRAPHIC) — 788KB
- img60816055_45.jpg (GRAPHIC) — 405KB
- img60816055_46.jpg (GRAPHIC) — 245KB
- img60816055_47.jpg (GRAPHIC) — 515KB
- img60816055_48.jpg (GRAPHIC) — 412KB
- img61739576_0.jpg (GRAPHIC) — 1KB
- img62663097_0.jpg (GRAPHIC) — 5KB
- 0000950170-24-131516.txt ( ) — 38682KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: November 27, 2024